Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-28T15:20:54.699Z Has data issue: false hasContentIssue false

P-1273 - Short Message Service to Improve Treatment Adherence and Quality of Life in Patients With Schizophrenia in Spain: the sms Study

Published online by Cambridge University Press:  15 April 2020

J.M. Montes
Affiliation:
Psychiatry Department, Sureste Hospital Madrid, Spain Medical Department, AstraZeneca Spain, Madrid, Spain
J. Maurino
Affiliation:
Psychiatry Department, Sureste Hospital Madrid, Spain Medical Department, AstraZeneca Spain, Madrid, Spain
E. Medina
Affiliation:
Psychiatry Department, Sureste Hospital Madrid, Spain Medical Department, AstraZeneca Spain, Madrid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Schizophrenia is a very incapacitating mental diseases. A lack of pharmacological adherence drives to an increased relapse and hospitalizations incidence. Strategies focused on improving adherence could benefit patients and improve their quality of life (QoL).

Objectives

To assess improvements on QoL by increasing treatment adherence.

Methods

This was a national, multicentre, open-label randomized clinical trial to evaluate the efficacy of a Short Message Service (SMS) system on improving adherence in schizophrenic patients. Patients in the SMS group received reminders via mobile phone about their medication during the first 3 months after inclusion. Controls were not sent any reminder and received standard care. Adherence was assessed by mean of the 4-item Morisky-Green test (Medication Adherence Questionnaire, MAQ) and attitude towards medication was assessed by the 10-Item Drug Attitude Inventory (DAI-10) at baseline and 3 and 6 months after the inclusion. QoL was assessed by the EuroQol (EQ-5D) questionnaire at the same visits.

Results

Based on Intention To Treat (ITT) population, 100 (39.4%) patients comprised the SMS Group, whereas 154 (60.6%) patients were controls. There were not statistically significant differences on demographic characteristics between both groups. More patients improved their adherence (MAQ) in SMS group compared to the control group [44.0% vs. 28.6% (p = 0.012)]. No significant differences were found regarding attitude towards medication (DAI-10), however improvements in DAI-10 were associated with improvements in EQ-5D [82.5% vs. 64.9% (p = 0.029)].

Conclusions

SMS reminders improved adherence to treatment and improved patients’ outcomes with a positive impact on QoL.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.